Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00134-018-5308-4.

Title:
Intensive care support and clinical outcomes of patients with Ebola virus disease (EVD) in West Africa | Intensive Care Medicine
Description:
Purpose We investigate the impact on outcome of different levels of supportive treatment in Ebola virus disease (EVD). The NGO EMERGENCY delivered care sequentially at two Ebola Treatment Centres (ETC) in Sierra Leone: first at Lakka (fluids, symptomatic, antibiotic, antimalaria treatment, and hospital level medical care), and thereafter in Goderich, adding organ support in the only African ETC with an equipped and staffed intensive care unit (ETC-ICU). Methods The primary outcome in this retrospective cohort study was in-ETC mortality. Secondarily, we used multivariable logistic regression to investigate the independent impact of the IC on mortality by comparing patients in two ETCs, adjusting for potential confounders, including the viral load (base-10 logarithm in copies/ml) (LVL), modelled as a piecewise linear function. Mortality was plotted versus LVL. Confidence bands were constructed by a bootstrap technique. The number of hospital-free days within 28 was computed to assess the burden of EVD. Results Data from 229 EVD patients were analysed (123 in Lakka, 106 in Goderich). Crude analysis showed a non-statistically significant difference in mortality (57.7% in Lakka vs 50.0% in Goderich; p = 0.19). Age and LVL were associated with mortality. Adjusted mortality was lower at the Goderich ICU-ETC (p = 0.055). This difference was observed with 80% confidence for patients with LVL between 7.5 and 8.5 copies/ml. Hospital-free days (of 28 days) were greater (7.7 vs 5.5; p = 0.03) for patients treated in the ICU-ETC. Conclusions Provision of critical care to patients with EVD is feasible in resource-limited settings and was associated with improved survival and less time in hospital.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Insurance

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

patients, ebola, care, article, treatment, pubmed, evd, viral, lvl, google, scholar, virus, goderich, mortality, intensive, load, admission, disease, confidence, patient, lakka, clinical, days, sierra, table, med, cas, leone, etcs, supplementary, central, study, material, time, icu, analysis, information, outcome, trial, outcomes, africa, access, supportive, emergency, level, age, treated, outbreak, centre, values,

Topics {✒️}

pre-existing chronical illness article download pdf intensive care medicine kaplan–meier survival-curve critical care medicine foreign affairs–direzione general wilcoxon rank-sum test west africa-unpredictable risks central venous catheter medium–high viral loads ricerca corrente irccs liliane chatenoud reverse organ failure intensive care support ebola holding center central venous pressure intensive care unit full size table rt-pcr test results intensive supportive care multivariable logistic regression intensive care approach org/ebola-guidelines/listing ebola virus infection privacy choices/manage cookies ebola virus disease providing intensive care adding organ support organ-supporting care intensive care availability ebola patient survival single-arm proof recently published guidelines optimise supportive care bootstrap-based confidence band rossella miccio piecewise linear transformations kaplan–meier curves high viral loads article langer critical care provision infectious disease specialists full access realstar filovirus screen exhibited promising findings creative commons license search search ebola treatment centres related electrolyte imbalances medical assessment/support

Questions {❓}

  • Payton ME, Greenstone MH, Schenker N (2003) Overlapping confidence intervals or standard error intervals: what do they mean in terms of statistical significance?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Intensive care support and clinical outcomes of patients with Ebola virus disease (EVD) in West Africa
         description:We investigate the impact on outcome of different levels of supportive treatment in Ebola virus disease (EVD). The NGO EMERGENCY delivered care sequentially at two Ebola Treatment Centres (ETC) in Sierra Leone: first at Lakka (fluids, symptomatic, antibiotic, antimalaria treatment, and hospital level medical care), and thereafter in Goderich, adding organ support in the only African ETC with an equipped and staffed intensive care unit (ETC-ICU). The primary outcome in this retrospective cohort study was in-ETC mortality. Secondarily, we used multivariable logistic regression to investigate the independent impact of the IC on mortality by comparing patients in two ETCs, adjusting for potential confounders, including the viral load (base-10 logarithm in copies/ml) (LVL), modelled as a piecewise linear function. Mortality was plotted versus LVL. Confidence bands were constructed by a bootstrap technique. The number of hospital-free days within 28 was computed to assess the burden of EVD. Data from 229 EVD patients were analysed (123 in Lakka, 106 in Goderich). Crude analysis showed a non-statistically significant difference in mortality (57.7% in Lakka vs 50.0% in Goderich; p = 0.19). Age and LVL were associated with mortality. Adjusted mortality was lower at the Goderich ICU-ETC (p = 0.055). This difference was observed with 80% confidence for patients with LVL between 7.5 and 8.5 copies/ml. Hospital-free days (of 28 days) were greater (7.7 vs 5.5; p = 0.03) for patients treated in the ICU-ETC. Provision of critical care to patients with EVD is feasible in resource-limited settings and was associated with improved survival and less time in hospital.
         datePublished:2018-07-30T00:00:00Z
         dateModified:2018-07-30T00:00:00Z
         pageStart:1266
         pageEnd:1275
         sameAs:https://doi.org/10.1007/s00134-018-5308-4
         keywords:
            Ebola virus disease
            Intensive care
            Multiple organ failure
            Health-care in resource limited countries
            Intensive / Critical Care Medicine
            Anesthesiology
            Emergency Medicine
            Pneumology/Respiratory System
            Pain Medicine
            Pediatrics
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00134-018-5308-4/MediaObjects/134_2018_5308_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00134-018-5308-4/MediaObjects/134_2018_5308_Fig2_HTML.png
         isPartOf:
            name:Intensive Care Medicine
            issn:
               1432-1238
               0342-4642
            volumeNumber:44
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Martin Langer
               url:http://orcid.org/0000-0002-8496-1620
               affiliation:
                     name:University of Milan
                     address:
                        name:Dipartimento di Oncologia e Onco-Ematologia, University of Milan, Milan, Italy
                        type:PostalAddress
                     type:Organization
                     name:IRCCS Istituto Nazionale dei Tumori
                     address:
                        name:IRCCS Istituto Nazionale dei Tumori, Milan, Italy
                        type:PostalAddress
                     type:Organization
                     name:EMERGENCY-NGO
                     address:
                        name:EMERGENCY-NGO, Milan, Italy
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Gina Portella
               affiliation:
                     name:EMERGENCY-NGO
                     address:
                        name:EMERGENCY-NGO, Milan, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stefano Finazzi
               affiliation:
                     name:IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”
                     address:
                        name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Liliane Chatenoud
               affiliation:
                     name:IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”
                     address:
                        name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Simone Lanini
               affiliation:
                     name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”
                     address:
                        name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Francesco Vairo
               affiliation:
                     name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”
                     address:
                        name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Robert Fowler
               affiliation:
                     name:Sunnybrook Hospital
                     address:
                        name:Departments of Medicine and Critical Care Medicine, Sunnybrook Hospital, Toronto, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rossella Miccio
               affiliation:
                     name:EMERGENCY-NGO
                     address:
                        name:EMERGENCY-NGO, Milan, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Giuseppe Ippolito
               affiliation:
                     name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”
                     address:
                        name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Guido Bertolini
               affiliation:
                     name:IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”
                     address:
                        name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gino Strada
               affiliation:
                     name:EMERGENCY-NGO
                     address:
                        name:EMERGENCY-NGO, Milan, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Intensive care support and clinical outcomes of patients with Ebola virus disease (EVD) in West Africa
      description:We investigate the impact on outcome of different levels of supportive treatment in Ebola virus disease (EVD). The NGO EMERGENCY delivered care sequentially at two Ebola Treatment Centres (ETC) in Sierra Leone: first at Lakka (fluids, symptomatic, antibiotic, antimalaria treatment, and hospital level medical care), and thereafter in Goderich, adding organ support in the only African ETC with an equipped and staffed intensive care unit (ETC-ICU). The primary outcome in this retrospective cohort study was in-ETC mortality. Secondarily, we used multivariable logistic regression to investigate the independent impact of the IC on mortality by comparing patients in two ETCs, adjusting for potential confounders, including the viral load (base-10 logarithm in copies/ml) (LVL), modelled as a piecewise linear function. Mortality was plotted versus LVL. Confidence bands were constructed by a bootstrap technique. The number of hospital-free days within 28 was computed to assess the burden of EVD. Data from 229 EVD patients were analysed (123 in Lakka, 106 in Goderich). Crude analysis showed a non-statistically significant difference in mortality (57.7% in Lakka vs 50.0% in Goderich; p = 0.19). Age and LVL were associated with mortality. Adjusted mortality was lower at the Goderich ICU-ETC (p = 0.055). This difference was observed with 80% confidence for patients with LVL between 7.5 and 8.5 copies/ml. Hospital-free days (of 28 days) were greater (7.7 vs 5.5; p = 0.03) for patients treated in the ICU-ETC. Provision of critical care to patients with EVD is feasible in resource-limited settings and was associated with improved survival and less time in hospital.
      datePublished:2018-07-30T00:00:00Z
      dateModified:2018-07-30T00:00:00Z
      pageStart:1266
      pageEnd:1275
      sameAs:https://doi.org/10.1007/s00134-018-5308-4
      keywords:
         Ebola virus disease
         Intensive care
         Multiple organ failure
         Health-care in resource limited countries
         Intensive / Critical Care Medicine
         Anesthesiology
         Emergency Medicine
         Pneumology/Respiratory System
         Pain Medicine
         Pediatrics
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00134-018-5308-4/MediaObjects/134_2018_5308_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00134-018-5308-4/MediaObjects/134_2018_5308_Fig2_HTML.png
      isPartOf:
         name:Intensive Care Medicine
         issn:
            1432-1238
            0342-4642
         volumeNumber:44
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Martin Langer
            url:http://orcid.org/0000-0002-8496-1620
            affiliation:
                  name:University of Milan
                  address:
                     name:Dipartimento di Oncologia e Onco-Ematologia, University of Milan, Milan, Italy
                     type:PostalAddress
                  type:Organization
                  name:IRCCS Istituto Nazionale dei Tumori
                  address:
                     name:IRCCS Istituto Nazionale dei Tumori, Milan, Italy
                     type:PostalAddress
                  type:Organization
                  name:EMERGENCY-NGO
                  address:
                     name:EMERGENCY-NGO, Milan, Italy
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Gina Portella
            affiliation:
                  name:EMERGENCY-NGO
                  address:
                     name:EMERGENCY-NGO, Milan, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stefano Finazzi
            affiliation:
                  name:IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”
                  address:
                     name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Liliane Chatenoud
            affiliation:
                  name:IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”
                  address:
                     name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Simone Lanini
            affiliation:
                  name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”
                  address:
                     name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Francesco Vairo
            affiliation:
                  name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”
                  address:
                     name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Robert Fowler
            affiliation:
                  name:Sunnybrook Hospital
                  address:
                     name:Departments of Medicine and Critical Care Medicine, Sunnybrook Hospital, Toronto, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rossella Miccio
            affiliation:
                  name:EMERGENCY-NGO
                  address:
                     name:EMERGENCY-NGO, Milan, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Giuseppe Ippolito
            affiliation:
                  name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”
                  address:
                     name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Guido Bertolini
            affiliation:
                  name:IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”
                  address:
                     name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gino Strada
            affiliation:
                  name:EMERGENCY-NGO
                  address:
                     name:EMERGENCY-NGO, Milan, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Intensive Care Medicine
      issn:
         1432-1238
         0342-4642
      volumeNumber:44
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Milan
      address:
         name:Dipartimento di Oncologia e Onco-Ematologia, University of Milan, Milan, Italy
         type:PostalAddress
      name:IRCCS Istituto Nazionale dei Tumori
      address:
         name:IRCCS Istituto Nazionale dei Tumori, Milan, Italy
         type:PostalAddress
      name:EMERGENCY-NGO
      address:
         name:EMERGENCY-NGO, Milan, Italy
         type:PostalAddress
      name:EMERGENCY-NGO
      address:
         name:EMERGENCY-NGO, Milan, Italy
         type:PostalAddress
      name:IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”
      address:
         name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
         type:PostalAddress
      name:IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”
      address:
         name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
         type:PostalAddress
      name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”
      address:
         name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
         type:PostalAddress
      name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”
      address:
         name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
         type:PostalAddress
      name:Sunnybrook Hospital
      address:
         name:Departments of Medicine and Critical Care Medicine, Sunnybrook Hospital, Toronto, Canada
         type:PostalAddress
      name:EMERGENCY-NGO
      address:
         name:EMERGENCY-NGO, Milan, Italy
         type:PostalAddress
      name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”
      address:
         name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
         type:PostalAddress
      name:IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”
      address:
         name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
         type:PostalAddress
      name:EMERGENCY-NGO
      address:
         name:EMERGENCY-NGO, Milan, Italy
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Martin Langer
      url:http://orcid.org/0000-0002-8496-1620
      affiliation:
            name:University of Milan
            address:
               name:Dipartimento di Oncologia e Onco-Ematologia, University of Milan, Milan, Italy
               type:PostalAddress
            type:Organization
            name:IRCCS Istituto Nazionale dei Tumori
            address:
               name:IRCCS Istituto Nazionale dei Tumori, Milan, Italy
               type:PostalAddress
            type:Organization
            name:EMERGENCY-NGO
            address:
               name:EMERGENCY-NGO, Milan, Italy
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Gina Portella
      affiliation:
            name:EMERGENCY-NGO
            address:
               name:EMERGENCY-NGO, Milan, Italy
               type:PostalAddress
            type:Organization
      name:Stefano Finazzi
      affiliation:
            name:IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”
            address:
               name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
               type:PostalAddress
            type:Organization
      name:Liliane Chatenoud
      affiliation:
            name:IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”
            address:
               name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
               type:PostalAddress
            type:Organization
      name:Simone Lanini
      affiliation:
            name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”
            address:
               name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
               type:PostalAddress
            type:Organization
      name:Francesco Vairo
      affiliation:
            name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”
            address:
               name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
               type:PostalAddress
            type:Organization
      name:Robert Fowler
      affiliation:
            name:Sunnybrook Hospital
            address:
               name:Departments of Medicine and Critical Care Medicine, Sunnybrook Hospital, Toronto, Canada
               type:PostalAddress
            type:Organization
      name:Rossella Miccio
      affiliation:
            name:EMERGENCY-NGO
            address:
               name:EMERGENCY-NGO, Milan, Italy
               type:PostalAddress
            type:Organization
      name:Giuseppe Ippolito
      affiliation:
            name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”
            address:
               name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
               type:PostalAddress
            type:Organization
      name:Guido Bertolini
      affiliation:
            name:IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”
            address:
               name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
               type:PostalAddress
            type:Organization
      name:Gino Strada
      affiliation:
            name:EMERGENCY-NGO
            address:
               name:EMERGENCY-NGO, Milan, Italy
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Dipartimento di Oncologia e Onco-Ematologia, University of Milan, Milan, Italy
      name:IRCCS Istituto Nazionale dei Tumori, Milan, Italy
      name:EMERGENCY-NGO, Milan, Italy
      name:EMERGENCY-NGO, Milan, Italy
      name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
      name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
      name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
      name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
      name:Departments of Medicine and Critical Care Medicine, Sunnybrook Hospital, Toronto, Canada
      name:EMERGENCY-NGO, Milan, Italy
      name:IRCCS Istituto Nazionale Malattie Infettive “Lazzaro Spallanzani”, Rome, Italy
      name:Dipartimento di Epidemiologia Clinica, IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Ranica, Italy
      name:EMERGENCY-NGO, Milan, Italy

External Links {🔗}(152)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Bootstrap
  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

6.17s.